- Home
- SINT vs SYRS Comparison
SINT vs SYRS Comparison
Compare SINT & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- SYRS
- Stock Information
- Founded
- SINT 1996
- SYRS 2011
- Country
- SINT United States
- SYRS United States
- Employees
- SINT N/A
- SYRS N/A
- Industry
- SINT Medical/Dental Instruments
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- SYRS Health Care
- Exchange
- SINT Nasdaq
- SYRS Nasdaq
- Market Cap
- SINT 4.1M
- SYRS 3.6M
- IPO Year
- SINT 2014
- SYRS 2016
- Fundamental
- Price
- SINT $3.24
- SYRS $0.08
- Analyst Decision
- SINT
- SYRS Hold
- Analyst Count
- SINT 0
- SYRS 5
- Target Price
- SINT N/A
- SYRS $3.00
- AVG Volume (30 Days)
- SINT 4.0M
- SYRS 41.3M
- Earning Date
- SINT 03-26-2025
- SYRS 03-26-2025
- Dividend Yield
- SINT N/A
- SYRS N/A
- EPS Growth
- SINT N/A
- SYRS N/A
- EPS
- SINT N/A
- SYRS N/A
- Revenue
- SINT $3,247,000.00
- SYRS $386,000.00
- Revenue This Year
- SINT $18.23
- SYRS N/A
- Revenue Next Year
- SINT N/A
- SYRS N/A
- P/E Ratio
- SINT N/A
- SYRS N/A
- Revenue Growth
- SINT 30.40
- SYRS N/A
- 52 Week Low
- SINT $2.01
- SYRS $0.07
- 52 Week High
- SINT $45.60
- SYRS $6.93
- Technical
- Relative Strength Index (RSI)
- SINT 44.59
- SYRS 45.55
- Support Level
- SINT $3.16
- SYRS $0.07
- Resistance Level
- SINT $3.75
- SYRS $0.10
- Average True Range (ATR)
- SINT 0.65
- SYRS 0.03
- MACD
- SINT -0.11
- SYRS 0.00
- Stochastic Oscillator
- SINT 9.65
- SYRS 30.62
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.